3-38771336-T-G
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_006514.4(SCN10A):c.542A>C(p.Glu181Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E181G) has been classified as Uncertain significance.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN10A | NM_006514.4 | c.542A>C | p.Glu181Ala | missense_variant | Exon 5 of 28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.542A>C | p.Glu181Ala | missense_variant | Exon 5 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.542A>C | p.Glu181Ala | missense_variant | Exon 4 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.542A>C | p.Glu181Ala | missense_variant | Exon 5 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152178Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251462 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function
Brugada syndrome Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 181 of the SCN10A protein (p.Glu181Ala). This variant is present in population databases (rs142203439, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with SCN10A-related conditions. ClinVar contains an entry for this variant (Variation ID: 532072). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at